That's right they know how essential it is. Even in the face of declining birth rates A2 have managed to gain roughly 2.5% of MBS market share (and a good portion of CBEC). They achieved this through taking market share from competitors. Moreover with the rising middle class there is a larger portion of people buying premium IF - local and foreign. On top of that, we could even see a bigger % of Chinese mothers opting to use formula rather than breast-feeding (this is just my assumption) but that also creates more demand for iF.
Media Updates, page-9753
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.96 |
Change
0.035(0.71%) |
Mkt cap ! $3.569B | |||
| Open | High | Low | Value | Volume |
| $4.93 | $4.96 | $4.89 | $1.846M | 374.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 7415 | $4.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.96 | 14111 | 16 |
View Market Depth
| Last trade - 13.10pm 19/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |